Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064918

Chief R&D Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zalevsky Jonathan · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-18 Grant or award : show line 1 in the form +40,000 290,317 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-18 Grant or award : show line 2 in the form Stock Option +71,500 71,500 D
Loading xslF345X03/doc4.xml…